This conference presented the findings and recommendations from an National Science Foundation-funded project on "NIRT: Evaluating Oversight Models for Active Nanostructures and Nanosystems: Learning from Past Technologies in a Societal Context." The project assessed five historical oversight models--for drugs, devices, gene transfer, genetically engineered organisms in the food supply, and chemicals in the workplace — using a comparative approach, and developed recommendations for future nanobiotechnology oversight. The conference assembled a multi-disciplinary group of investigators with strengths in nanotechnology research and development, public policy, law, health, environment, economics, and bioethics as well as collaborators representing a range of perspectives who presented their findings to key leaders from related oversight agencies and the public.
The conference included sessions providing background information in nanobiotechnology and existing oversight systems. The investigators then presented their recommendations, and a panel of experts provided input before opening up the discussion to the audience. Break-out sessions focused on nanoethics, risk assessment, public engagement, and law and regulatory approaches.
Continuing Education Units
Approved for 6.5 standard CLE credits. Event #141994.
This event has been designated by the Office of the Vice President for Research to satisfy the Awareness/Discussion component of the Responsible Conduct of Research (RCR) continuing education requirement.
|The conference is sponsored by the University of Minnesota's: